These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 37098997)
1. TRAIL and EGFR Pathways Targeting microRNAs are Predominantly Regulated in Human Diabetic Nephropathy. Rai B; Pande A; Tiwari S Microrna; 2023; 12(2):143-155. PubMed ID: 37098997 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of urine exosomes derived from rats with diabetic kidney disease. Mishra DD; Sahoo B; Maurya PK; Sharma R; Varughese S; Prasad N; Tiwari S Front Endocrinol (Lausanne); 2023; 14():1157194. PubMed ID: 37251672 [TBL] [Abstract][Full Text] [Related]
3. Identification of urinary extracellular vesicles differentially expressed RNAs in diabetic nephropathy via whole-transcriptome integrated analysis. Zhao Z; Yan Q; Fang L; Li G; Liu Y; Li J; Pan S; Zhou S; Duan J; Liu D; Liu Z Comput Biol Med; 2023 Nov; 166():107480. PubMed ID: 37738894 [TBL] [Abstract][Full Text] [Related]
4. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients. Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277 [TBL] [Abstract][Full Text] [Related]
5. Construction and Bioinformatics Analysis of the miRNA-mRNA Regulatory Network in Diabetic Nephropathy. Li Y; Xu Y; Hou Y; Li R J Healthc Eng; 2021; 2021():8161701. PubMed ID: 34840704 [TBL] [Abstract][Full Text] [Related]
6. Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies. Gholaminejad A; Abdul Tehrani H; Gholami Fesharaki M J Nephrol; 2018 Dec; 31(6):813-831. PubMed ID: 30019103 [TBL] [Abstract][Full Text] [Related]
7. Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management. Peng L; Chen Y; Shi S; Wen H Stem Cell Res Ther; 2022 Jan; 13(1):25. PubMed ID: 35073973 [TBL] [Abstract][Full Text] [Related]
8. Potential Value of Urinary Exosome-Derived let-7c-5p in the Diagnosis and Progression of Type II Diabetic Nephropathy. Li W; Yang S; Qiao R; Zhang J Clin Lab; 2018 May; 64(5):709-718. PubMed ID: 29739042 [TBL] [Abstract][Full Text] [Related]
9. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy Guo M; Dai Y; Jiang L; Gao J Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518 [TBL] [Abstract][Full Text] [Related]
10. Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy. Ming J; Sana SRGL; Deng X Front Endocrinol (Lausanne); 2022; 13():978601. PubMed ID: 36329882 [TBL] [Abstract][Full Text] [Related]
11. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy. Dai Y; Guo M; Jiang L; Gao J Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030 [TBL] [Abstract][Full Text] [Related]
12. Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets. Hojjati F; Roointan A; Gholaminejad A; Eshraghi Y; Gheisari Y Nefrologia (Engl Ed); 2023; 43(5):575-586. PubMed ID: 36681521 [TBL] [Abstract][Full Text] [Related]
13. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis. Eissa S; Matboli M; Bekhet MM Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555 [TBL] [Abstract][Full Text] [Related]
14. PTGER3 and MMP-2 play potential roles in diabetic nephropathy via competing endogenous RNA mechanisms. Yu Y; Jia YY; Wang M; Mu L; Li HJ BMC Nephrol; 2021 Jan; 22(1):27. PubMed ID: 33435900 [TBL] [Abstract][Full Text] [Related]
15. Phosphoproteome Profiling of uEVs Reveals p-AQP2 and p-GSK3β as Potential Markers for Diabetic Nephropathy. Li Q; Zhang J; Fang Y; Dai Y; Jia P; Shen Z; Xu S; Ding X; Zhou F Molecules; 2023 Jul; 28(14):. PubMed ID: 37513479 [TBL] [Abstract][Full Text] [Related]
16. The circulating exosomal microRNAs related to albuminuria in patients with diabetic nephropathy. Kim H; Bae YU; Jeon JS; Noh H; Park HK; Byun DW; Han DC; Ryu S; Kwon SH J Transl Med; 2019 Jul; 17(1):236. PubMed ID: 31331349 [TBL] [Abstract][Full Text] [Related]
17. Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan. Chien HY; Chen CY; Chiu YH; Lin YC; Li WC Int J Med Sci; 2016; 13(6):457-65. PubMed ID: 27279796 [TBL] [Abstract][Full Text] [Related]
18. Identification of miRNAs-genes regulatory network in diabetic nephropathy based on bioinformatics analysis. Yang F; Cui Z; Deng H; Wang Y; Chen Y; Li H; Yuan L Medicine (Baltimore); 2019 Jul; 98(27):e16225. PubMed ID: 31277135 [TBL] [Abstract][Full Text] [Related]
19. Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis. Hu Y; Yu Y; Dong H; Jiang W PeerJ; 2023; 11():e15437. PubMed ID: 37250717 [TBL] [Abstract][Full Text] [Related]